99% Savings - Buy Just @1 Rs X
Taf Plus is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Taf Plus is used -
Common
Is the use of Taf Plus safe for pregnant women?
Side effects of Taf Plus during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Taf Plus safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Taf Plus for breastfeeding women are not known.
What is the effect of Taf Plus on the Kidneys?
Taf Plus is not harmful for kidneys.
What is the effect of Taf Plus on the Liver?
There are no any side effects of Taf Plus on the liver.
What is the effect of Taf Plus on the Heart?
Taf Plus is completely safe for the heart.
Taf Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Taf Plus unless your doctor advises you to do so -
Is this Taf Plus habit forming or addictive?
No, there is no any evidence that Taf Plus is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Taf Plus as it does not make you drowsy.
Is it safe?
Taf Plus should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Taf Plus cannot treat any kind of mental disorder.
Interaction between Food and Taf Plus
Due to the absence of research, it is difficult to say how Taf Plus and food will interact.
Interaction between Alcohol and Taf Plus
Information about the interaction of Taf Plus and alcohol is not currently available because this topic has not been researched yet.
Yes, Taf Plus is a steroid. It contains clobetasol which is a potent corticosteroid. It should not be confused with anabolic-androgenic steroids which are used by some bodybuilders without prescription to build muscle mass.
Taf Plus is used for the short-term treatment up to 2 weeks and if required then maximum up to 4 weeks. You are advised to use it as directed by your doctor. Do not use this medicine longer than prescribed by your doctor to avoid the unpleasant side effect.
Taf Plus contains clobetasol which is presumed to work by promoting the induction of inhibitory proteins (lipocortins) in the body. Lipocortins prevents the release of arachidonic acid which causes synthesis and release of certain chemicals such as histamine, leukotrienes, and prostaglandins that causes inflammation. In this way Taf Plus prevents the skin inflammation which provides relief to the patient from rash, itching, and redness.
Yes, Taf Plus might cause hair loss (alopecia). It is a rare side effect of this drug and the exact cause behind hair loss is unknown. For partial hair loss, you are advised to use hair solution such as minoxidil.
Yes, Taf Plus might cause dry skin in few cases only. However, the exact cause behind dry skin is unknown. If you are experiencing excessive dryness of skin after applying this drug then you are advised to use a skin moisturizer. Skin moisturizer should be applied only after 30 minutes of applying this drug so that the Taf Plus can be absorbed by the skin.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
SmPC [Internet]: Dermovate Cream (clobetasol propionate). GlaxoSmithKline UK
Description and Brand Names [Internet]: Drugs and Supplements Terbinafine (Topical Route). IBM Micromedex